AliveDx Suisse S.A. and Medical Development Medical Devices WLL have signed a distribution agreement, which will enable Medical Development Medical Devices to distribute the MosaiQ® solution in the Kingdom of Bahrain. The distribution agreement takes effect immediately.
AliveDx is dedicated to expanding its reach and presence across various regions. This strategic collaboration with a solid partner in the Kingdom of Bahrain emphasizes the company’s commitment to supporting the healthcare sector and enhancing patient care.
The MosaiQ platform simplifies workflows and creates efficiencies thanks to its multiplexing microarray assay technology. This streamlined and efficient approach offers faster and more cost-effective solutions to healthcare providers and patients alike.
“AliveDx’s partnership with Medical Development Medical Devices is an outstanding opportunity to showcase our commitment to transforming patient care worldwide and supporting the healthcare system through innovative, clinically relevant, accurate, and fast diagnostic solutions,” said Manuel O. Méndez, AliveDx’s CEO.
Medical Development Medical Devices is a healthcare company founded in 2014. The company distributes high-quality medical products, offering exceptional 24/7 expert sales and after-sales support services.
“We are excited to collaborate with AliveDx. The innovative MosaiQ microarray multiplexing diagnostic solution will further strengthen our portfolio and help us provide the Kingdom of Bahrain’s healthcare sector with the latest innovative technologies to support patient care,” said Mohamed Maher, Business Development Manager, Medical Development Medical Devices.
